Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BQ-788 in Human Melanoma
NCT02442466Phase 1Terminated
- Sponsor
- MELCURE SA
- Start
- May 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
01
Overview
Phase 1, single-blind trial of BQ-788 in melanoma (2 arms), sponsored by MELCURE SA. Primary endpoint: Tumour response by size measurement and histological examination. Started May 2011; status: terminated.
02
Drugs
BQ-788
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02442466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02442466.